NXL 株価分析 — Nexalin Technology Inc. (Healthcare >> Medical Devices)
NXL に関するよくある質問
NXLのROE(自己資本利益率)は?
Nexalin Technology Inc.のROEは-288.63%です。
NXLの配当利回りは?
Nexalin Technology Inc.の配当利回りは0.00%です。
NXLの品質スコア(Quality Score)は?
当社のAIはNXLの総合財務品質を100点中31点と評価しています。収益性・成長性・負債・利益の安定性に基づく評価です。
NXLは今が買い時ですか?
当社AIのタイミングスコアは100点中28点で、テクニカル指標とモメンタムから見た現在価格の相対的な魅力度を示します。
NXLはどのセクターに属しますか?
Nexalin Technology Inc.はHealthcare >> Medical Devicesセクターに分類されます(NASDAQ市場)
NXL AI Analysis Summary
Our AI summary for NXL: Nexalin Technology Inc. (NASDAQ), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 0.00, ROE of -288.63%, a dividend yield of 0.00%. Its financial Quality Score stands at 31/100 — fundamentals below the market average. The AI Timing Score is 28/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.36
Price
0.03
(8.02%)
Day Change
|
|
|---|
NXL, ファンダメンタルスコアはnot good ( ファンダメンタル = 31) そして テクニカルスコアは ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...
| Deepscope 分析 |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.36 |
| PBV / Sector |
2.58 / -101.53
|
| Earning Per Share | -0.41 |
| PE / Sector |
N/A / 31.42
|
| PEG or PE/Growth / Sector |
N/A / 0.35
|
| Average 1M Daily Value |
0.12 M
GREAT
|
| Average 1W Daily Value |
0.09 M
GREAT
|
| Timing Factors |
|
28% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
56% |
| 配当 |
|
4% |
| 登録情報 |
| Analyze Date | 2026-08-04 08:01:56 |
| Symbol | NXL |
| Name | NEXALIN TECHNOLOGY INC. |
| Sector | Healthcare >> Medical Devices |
| Market | NASDAQ |
| Listed Shares | 22.01 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 7.44 / 20,008.89 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 1776 Yorktown, Houston, TX, United States, 77056
Phone: 832 260 0222
Website: https://www.nexalin.com
Sector: Healthcare >> Medical Devices
Description: Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health epidemic in the United States and China. The company offers Generation 1, an easy-to-administer medical device which utilizes bioelectronic medical technology to treat anxiety, insomnia, and depression without the need for drugs or psychotherapy; and Generation 2 and Generation 3 headset devices for the treatment of depression, substance use disorder, traumatic brain injury, post-traumatic stress disorder, opioid addiction, alcoholism, and chronic pain, as well as alzheimer's disease, and dementia. Nexalin Technology, Inc. is headquartered in Houston, Texas.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
Google